Virtu Financial’s Urovant Sciences Ltd. UROV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-14,792
Closed -$239K 2330
2020
Q4
$239K Buy
+14,792
New +$183K 0.03% 762

Virtu Financial's UROV Position: Q1 2021 in Review

Virtu Financial sold out of Urovant Sciences Ltd. (UROV) in Q1 2021, closing a stake of 14,792 shares — an estimated $239K sold.

Virtu Financial first reported a position in UROV in Q4 2020 and held it in 1 quarter. The position peaked at $239K in Q4 2020. 0 funds tracked by Wall St. Rank hold UROV as of Q1 2021.

  • Virtu Financial reported no remaining Urovant Sciences Ltd. position as of Q1 2021 after selling out during the quarter.
  • Virtu Financial sold 14,792 Urovant Sciences Ltd. shares in Q1 2021, an estimated $239K.
  • Virtu Financial first reported a position in Urovant Sciences Ltd. in Q4 2020 and held it in 1 quarter.
  • Virtu Financial's Urovant Sciences Ltd. position peaked at $239K in Q4 2020.
  • 0 funds tracked by Wall St. Rank held Urovant Sciences Ltd. as of Q1 2021.

Based on Virtu Financial's 13F filing for Q1 2021, filed 19 May 2021.